References
- Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2010. Natl Vital Stat Rep 2013;61:1-117
- Sachdeva A, Cannon C, Deedwania P, et al. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get with the Guidelines. Am Heart J 2009;157:111-7.e2
- Goff DC, Jr Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;129(25 Suppl 2):S49-73
- 2013 prevention guidelines tools: CV risk calculator. American College of Cardiology/American Heart Association, 2013. http://my.americanheart.org/professional/StatementsGuidelines/PreventionGuidelines/Prevention-Guidelines_UCM_457698_SubHomePage.jsp. Accessed July 15, 2014
- Penn MS, Klemes AB. Multimarker approach for identifying and documenting mitigation of cardiovascular risk. Future Cardiol 2013;9:497-506
- Pencina MJ, Navar-Boggan AM, D'Agostino RB, Sr et al. Application of new cholesterol guidelines to a population-based sample. N Engl J Med 2014;370:1422-31
- Howden LM, Meyer JA. Age and sex composition: 2010. Washington, DC: United States Census Bureau, 2011
- Witt BJ, Ballman KV, Brown RD Jr., et al. The incidence of stroke after myocardial infarction: a meta-analysis. Am J Med 2006;119:354.e1-9
- National Heart, Lung, and Blood Institute. Incidence and prevalence: 2006 chart book on cardiovascular and lung diseases. Bethesda, MD: National Institutes of Health, 2006
- Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics–2013 update: a report from the American Heart Association. Circulation 2013;127:e6-245
- Annual estimates of the resident population by sex, age, race alone or in combination, and Hispanic origin for the United States: April 1, 2010 to July 1, 2012. Washington, DC: United States Census Bureau, 2013
- O’Sullivan AK, Rubin J, Nyambose J, et al. Cost estimation of cardiovascular disease events in the US. PharmacoEconomics 2011;29:693-704
- Medicare Payment Advisory Commission (MedPAC). Approaches to bundling payment for post-acute care. Report to Congress: Medicare and the health care delivery system. MedPAC, 2013. MedPAC.gov. Accessed June 2013
- Consumer price index for all urban consumers (CPI-U): medical care. Washington, DC: Bureau of Labor Statistics, 2013
- Heslop CL, Frohlich JJ, Hill JS. Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography. J Am Coll Cardiol 2010;55:1102-9
- Folsom AR, Chambless LE, Ballantyne CM, et al. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. Arch Intern Med 2006;166:1368-73
- Ballantyne CM, Hoogeveen RC, Bang H, et al. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med 2005;165:2479-84
- Ridker P, Danielson E, Fonseca F, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-207
- Magnuson EA, Farkouh ME, Fuster V, et al. Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease: results from the FREEDOM trial. Circulation 2013;127:820-31